Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
01-Apr-2019 -
Dutch biotechnology company Micreos announced it has secured €30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin XZ.700 and theUSAlaunch of its OTC Gladskin ...
acne
antibiotic resistance
antibiotics
+7